VivoSeq
Other

Postoperative Pain Control

0

Pipeline Programs

5

Active Trials

0

Companies Involved

Postoperative Pain Control is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

64/100

Attrition Rate

28/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

58

clinical trials

Completed29 · 50%
Terminated12 · 21%
Unknown status8 · 14%
Withdrawn4 · 7%
Not yet recruiting4 · 7%
Recruiting1 · 2%

Trial Activity

58 trials

Dinalbuphine Sebacate in Postoperative Pain Control After TKA
Not yet recruiting·TThammasat University·Phase 4·NCT07140510·100 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)